Polar Capital’s NxStage Medical Inc. NXTM Stock Holding History

Polar Capital’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-541,612	Closed	-$14.5M	–	272
2017 Q1	$14.5M	Buy	541,612 +141,612	+35%	+$3.91M	0.22%	129
2016 Q4	$10.5M	Buy	400,000 +300,000	+300%	+$7.42M	0.17%	150
2016 Q3	$2.5M	Sell	100,000 -275,194	-73%	-$6.42M	0.04%	209
2016 Q2	$8.13M	Buy	+375,194	New	+$6.69M	0.15%	147

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Polar Capital's NXTM Position: Q2 2017 in Review

Polar Capital sold out of NxStage Medical Inc. (NXTM) in Q2 2017, closing a stake of 541,612 shares — an estimated $14.5M sold.

Polar Capital first reported a position in NXTM in Q2 2016 and held it in 4 quarters. The position peaked at $14.5M in Q1 2017. 163 funds tracked by Wall St. Rank hold NXTM as of Q2 2017.

Polar Capital reported no remaining NxStage Medical Inc. position as of Q2 2017 after selling out during the quarter.
Polar Capital sold 541,612 NxStage Medical Inc. shares in Q2 2017, an estimated $14.5M.
Polar Capital first reported a position in NxStage Medical Inc. in Q2 2016 and held it in 4 quarters.
Polar Capital's NxStage Medical Inc. position peaked at $14.5M in Q1 2017.
163 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2017.

Based on Polar Capital's 13F filing for Q2 2017, filed 14 Aug 2017.